<DOC>
	<DOCNO>NCT00738777</DOCNO>
	<brief_summary>To investigate prospectively whether short term endocrine treatment induce molecular change , predictive therapy response .</brief_summary>
	<brief_title>Pre-operative Hormonal Treatment Hormone Receptor Positive Breast Cancer</brief_title>
	<detailed_description>We perform randomize , open-label , single-institution study . It compare efficacy three different endocrine treatment regimen ( Anastrozole +/- Fulvestrant Tamoxifen ) change proliferation-index induce apoptosis 2-6 week pre-operative treatment period breast cancer patient . These result correlate gene expression profile , phosphorylation status ER , SNPs CYP450 sequence , tamoxifen metabolite concentration , change estrogen serum level protein expression pattern .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Patients proven invasive adenocarcinoma breast Any tumor size â‰¥ 1cm ( NOT inflammatory breast cancer ) WHOperformance score 0 1 Written inform consent Clues metastatic disease clinical examination accord recent NABON guideline Multicentric breast cancer Inflammatory breast cancer Hormone replacement last 12 month Other systemic treatment wait time till surgery Already plan date surgery within next 2 week Any psychological , familial , sociological geographical condition potentially hamper adequate inform consent compliance study protocol Patient 's refusal undergo core biopsy procedure primary tumor start treatment NB : concomitant malignancy within last five year exclusion criterium , survival primary endpoint . Just prior invasive breast cancer DCIS within last 15 year exclusion criterium . NB : Patients childbearing potential must implement adequate nonhormonal contraceptive measure study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>pre-operative</keyword>
	<keyword>endocrine treatment</keyword>
	<keyword>drug resistance</keyword>
</DOC>